Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Vesicare - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Vesicare

Approved

STANDARD

Vesicare

Astellas Pharma Europe B.V.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5af081a36aacd181
Company: Astellas Pharma Europe B.V.
Type: Standard

Approval Details

Approval Id: 5af081a36aacd181
Drug Approval Philippines Name: Vesicare
Product Name: Vesicare
Registration Number: DR-XY31760
Brand Name: Vesicare
Generic Name: Solifenacin succinate
Dosage Form: Film-coated tablet
Dosage Strength: 10mg
Manufacturer: Astellas Pharma Europe B.V.
Importer: Astellas Pharma Philippines, Inc.
Distributor: ZUELLIG PHARMA CORPORATION
Company Detail Path: /organization/astellas-pharma-europe-b-v
Issuance Date: 12 October 2024
Expiry Date: 10 October 2029
Pharmacologic Category: Muscarinic Receptor Antagonist
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5af081a36aacd181

Type

Standard

Back to Philippines FDA Approvals